MGMT and astrocytoma (excluding glioblastoma): Accordingly, the average methylation levels of the MGMT promoter was significantly lower in astrocytomas IDHwt (14.3%) versus both astrocytomas IDHmt (24.1%; p = 0.030) and oligodendrogliomas (32.4%; p = 0.0001).